| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $152.1M | -43.6% |
| Cost of Revenue | $15.4M | -49.9% |
| R&D Expense | $28.1M | -46.1% |
| SG&A Expense | $96.7M | -40.7% |
| Operating Income | -$114.3M | +72.9% |
| Interest Expense | $21.5M | -10.5% |
| Pre-tax Income | -$101.1M | +77.0% |
| Income Tax | $239K | +169.3% |
| Net Income | -$101.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $302.0M | -16.7% |
| Accounts Receivable | $5.9M | -17.2% |
| Current Assets | $324.7M | -35.3% |
| Total Assets | $395.8M | -36.3% |
| Current Liabilities | $49.9M | +0.7% |
| Long-term Debt | $123.9M | -54.6% |
| Total Liabilities | $185.3M | -45.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$71.8M | +60.0% |
| Investing Cash Flow | $168.3M | -46.0% |
| Financing Cash Flow | -$150.0M | -1314.0% |
| +76.9% |
| EPS (Basic) | -$4.85 | -353.3% |
| EPS (Diluted) | -$4.85 | -353.3% |
| Stockholders' Equity |
| $210.5M |
| -24.4% |